{"artifact":{"id":"wiki-therapeutics-tilavonemab","artifact_type":"wiki_page","entity_ids":"[\"therapeutics-tilavonemab\"]","title":"Tilavonemab (ABBV-8E12)","quality_score":0.5,"created_by":"crosslink-migration","provenance_chain":"[]","content_hash":"10bf07009b6ea54ffbb814a93240f3808597252bcc5410751d4c63eab62098b1","metadata":{"slug":"therapeutics-tilavonemab","kg_node_id":null,"entity_type":"therapeutic","origin_type":"v1_polymorphic_backfill","source_table":"wiki_pages","wiki_page_id":"wp-e1d2ba2d3ebd","__merged_from":{"merged_at":"2026-05-13","unprefixed_id":"therapeutics-tilavonemab"},"_schema_version":1},"created_at":"2026-04-02T07:18:58-07:00","updated_at":"2026-04-02T13:40:08-07:00","version_number":5,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":"2026-04-02T13:40:08-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":"ok","contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"de7fe973-d0de-4655-8acf-7033f7177099","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"crosslink-migration"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"hypothesis-h-aa8b4952","link_type":"supports","strength":0.75,"evidence":"Wiki page \"Tilavonemab (ABBV-8E12)\" references paper 31234567 which is cited by hypothesis"},{"target_artifact_id":"hypothesis-h-99b4e2d2","link_type":"supports","strength":0.75,"evidence":"Wiki page \"Tilavonemab (ABBV-8E12)\" references paper 31234567 which is cited by hypothesis"},{"target_artifact_id":"hypothesis-h-807d7a82","link_type":"supports","strength":0.75,"evidence":"Wiki page \"Tilavonemab (ABBV-8E12)\" references paper 31234567 which is cited by hypothesis"},{"target_artifact_id":"hypothesis-h-43f72e21","link_type":"supports","strength":0.75,"evidence":"Wiki page \"Tilavonemab (ABBV-8E12)\" references paper 31234567 which is cited by hypothesis"},{"target_artifact_id":"hypothesis-h-fd52a7a0","link_type":"supports","strength":0.75,"evidence":"Wiki page \"Tilavonemab (ABBV-8E12)\" references paper 31234567 which is cited by hypothesis"},{"target_artifact_id":"hypothesis-h-73e29e3a","link_type":"supports","strength":0.75,"evidence":"Wiki page \"Tilavonemab (ABBV-8E12)\" references paper 31234567 which is cited by hypothesis"},{"target_artifact_id":"analysis-SDA-2026-04-01-gap-006","link_type":"mentions","strength":0.4,"evidence":"Wiki page matches analysis keyword 'therapeutics'"},{"target_artifact_id":"analysis-SDA-2026-04-01-gap-008","link_type":"mentions","strength":0.4,"evidence":"Wiki page matches analysis keyword 'therapeutics'"},{"target_artifact_id":"experiment-exp-wiki-experiments-macroautophagy-dysfunction-parkinsons","link_type":"related","strength":0.7,"evidence":"Wiki page for MA related to experiment"},{"target_artifact_id":"hypothesis-h-5daecb6e","link_type":"mentions","strength":0.7,"evidence":"Drug 'TILAVONEMAB' mentioned in hypothesis"},{"target_artifact_id":"analysis-SDA-2026-04-01-gap-005","link_type":"related","strength":0.48999999999999994,"evidence":"Via hypothesis: Drug 'TILAVONEMAB' mentioned in hypothesis"},{"target_artifact_id":"hypothesis-h-0f00fd75","link_type":"mentions","strength":0.7,"evidence":"Drug 'TILAVONEMAB' mentioned in hypothesis"},{"target_artifact_id":"analysis-SDA-2026-04-02-gap-tau-prop-20260402003221","link_type":"related","strength":0.48999999999999994,"evidence":"Via hypothesis: Drug 'TILAVONEMAB' mentioned in hypothesis"},{"target_artifact_id":"hypothesis-h-8fe389e8","link_type":"mentions","strength":0.7,"evidence":"Drug 'TILAVONEMAB' mentioned in hypothesis"},{"target_artifact_id":"analysis-SDA-2026-04-02-gap-epigenetic-reprog-b685190e","link_type":"related","strength":0.48999999999999994,"evidence":"Via hypothesis: Drug 'TILAVONEMAB' mentioned in hypothesis"},{"target_artifact_id":"paper-31234567","link_type":"cites","strength":0.8,"evidence":"{\"pmid\": \"31234567\"}"},{"target_artifact_id":"hypothesis-h-f99ce4ca","link_type":"mentions","strength":0.5,"evidence":"Wiki content mentions gene P2RY12"},{"target_artifact_id":"wiki-mechanisms-tau-kinase-signaling-cascade","link_type":"see_also","strength":0.45,"evidence":"Pages share 3 hypotheses"}],"incoming_links":[{"source_artifact_id":"hypothesis-h-5daecb6e","link_type":"related","strength":0.63,"evidence":"Reverse: Drug 'TILAVONEMAB' mentioned in hypothesis"},{"source_artifact_id":"hypothesis-h-0f00fd75","link_type":"related","strength":0.63,"evidence":"Reverse: Drug 'TILAVONEMAB' mentioned in hypothesis"},{"source_artifact_id":"hypothesis-h-8fe389e8","link_type":"related","strength":0.63,"evidence":"Reverse: Drug 'TILAVONEMAB' mentioned in hypothesis"},{"source_artifact_id":"hypothesis-h-aa8b4952","link_type":"related","strength":0.675,"evidence":"Reverse: Wiki page \"Tilavonemab (ABBV-8E12)\" references paper 31234567 which is cited by hypothesis"},{"source_artifact_id":"hypothesis-h-99b4e2d2","link_type":"related","strength":0.675,"evidence":"Reverse: Wiki page \"Tilavonemab (ABBV-8E12)\" references paper 31234567 which is cited by hypothesis"},{"source_artifact_id":"hypothesis-h-807d7a82","link_type":"related","strength":0.675,"evidence":"Reverse: Wiki page \"Tilavonemab (ABBV-8E12)\" references paper 31234567 which is cited by hypothesis"},{"source_artifact_id":"hypothesis-h-43f72e21","link_type":"related","strength":0.675,"evidence":"Reverse: Wiki page \"Tilavonemab (ABBV-8E12)\" references paper 31234567 which is cited by hypothesis"},{"source_artifact_id":"hypothesis-h-fd52a7a0","link_type":"related","strength":0.675,"evidence":"Reverse: Wiki page \"Tilavonemab (ABBV-8E12)\" references paper 31234567 which is cited by hypothesis"},{"source_artifact_id":"hypothesis-h-73e29e3a","link_type":"related","strength":0.675,"evidence":"Reverse: Wiki page \"Tilavonemab (ABBV-8E12)\" references paper 31234567 which is cited by hypothesis"},{"source_artifact_id":"experiment-exp-wiki-experiments-macroautophagy-dysfunction-parkinsons","link_type":"related","strength":0.7,"evidence":"Experiment targets MA described in wiki"},{"source_artifact_id":"analysis-SDA-2026-04-01-gap-005","link_type":"related","strength":0.5,"evidence":"Reverse link"},{"source_artifact_id":"analysis-SDA-2026-04-01-gap-006","link_type":"related","strength":0.5,"evidence":"Reverse link"},{"source_artifact_id":"analysis-SDA-2026-04-01-gap-008","link_type":"related","strength":0.5,"evidence":"Reverse link"},{"source_artifact_id":"analysis-SDA-2026-04-02-gap-epigenetic-reprog-b685190e","link_type":"related","strength":0.5,"evidence":"Reverse link"},{"source_artifact_id":"analysis-SDA-2026-04-02-gap-tau-prop-20260402003221","link_type":"related","strength":0.5,"evidence":"Reverse link"},{"source_artifact_id":"wiki-mechanisms-tau-kinase-signaling-cascade","link_type":"see_also","strength":0.45,"evidence":"Pages share 3 hypotheses"}],"current_artifact_id":"wiki-therapeutics-tilavonemab","is_canonical":true,"supersede_chain":["wiki-therapeutics-tilavonemab"]}